医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

hromaDex Corp. (NASDAQ:CDXC) (“the Company”) a global bioscience company dedicated to healthy aging, today announced it has entered into an agreement (the “JV Agreement”) to establish a joint venture through its wholly owned subsidiary ChromaDex Asia Limited (the “JV” or “ChromaDex Asia”). Upon establishment of the JV, membership of ChromaDex Asia will collectively consist of the Company; Crystal Lake Developments Limited; Pioneer Idea Holdings Limited; and Hong Kong Taikuk (China) Group Limited. ChromaDex Asia is expected to assume the distribution agreement noted in a previous announced press release with Sinopharm Xingsha (“Sinopharm”) as it relates to the commercialization of Tru Niagen® in mainland China and its territories, excluding Hong Kong, Macau and Taiwan (the “Territory”). The JV’s entry into a distribution agreement will be contingent upon Sinopharm successfully attaining health food product registration for Tru Niagen® with the People’s Republic of China’s State Administration for Market Regulation (“SAMR”). SAMR is the regulatory body responsible for health food registration. Health food registration is a key regulatory step required to be able to broadly market and distribute Tru Niagen® products in China. Formation of the joint venture is subject to customary closing conditions.…　続きを読む

utdoor Retailer Summer Show — Wearable devices, once a novelty, are today a “must-have,” thanks in part to a heightened focus on healthful living and a growing comfort with technology. Now, wearables combined with smart textiles — “smart wearables”— are the upcoming hot items in the outdoor industry. Taiwan Excellence — the symbol encapsulating Taiwan’s best and most innovative products — will host a “Smart Tech, Smart Clothing: Innovations from Taiwan for the Outdoor Industry” webinar on May 26 to showcase and familiarize buyers with the country’s cutting-edge “smart wearables” designed for outdoor sports and fitness.…　続きを読む

Exscientia (Nasdaq: EXAI)是一家致力于以迅速而有效的方式来发现、设计和开发顶级药物的人工智能驱动型医药科技公司。该公司将于2022年5月25日（周三）美国市场收盘后公布截至2022年3月31日的第一季度财务业绩。随后，公司将于英国夏令时间2022年5月26日（周四）下午1:30/美国东部时间上午8:30举行电话会议和网络直播，概要介绍公司的精密医药平台。…　続きを読む

国際的食品・農業専門ベンチャーキャピタルのアンテラ・キャピタルでマネジング・パートナーを務めるアダム・アンダースは、破壊的なパンデミックや最近のウクライナにおける戦争により、投資家が世界の食品の生産、流通、消費方法を根本的に変える必要があると考えるようになったと伝えています。…　続きを読む